The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment By Annika Kim Constantino,CNBC • Published January 21, 2025 • Updated on January 21, 2025 at 11:04 am BOOKMARKER ...